✦ LIBER ✦

2 A novel innate immune antiviral mechanism of action of ribavirin in mammalian cells contributes to efficacy of combination therapy for hepatitis C

✍ Scribed by Emmanuel Thomas; Zongyi Hu; Stephen Dong; Jordan J. Feld; T. Jake Liang

Book ID: 116398274
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 124 KB
Volume: 43
Category: Article
ISSN: 1043-4666
DOI: 10.1016/j.cyto.2008.07.042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

113 A phase 2 dose-escalation study of a

113 A phase 2 dose-escalation study of albuferon combined with ribavirin in non-responders to prior interferon-based therapy for chronic hepatitis C infection

✍ V. Rustgi; D. Nelson; V. Balan; M. Sulkowski; L. Lambiase; G. Davis; A. Muir; R. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 108 KB

479 Moved to parallel session 7 safety a

479 Moved to parallel session 7 safety and efficacy of viramidine in combination with pegylated interferon alfa-2A for treatment of hepatitis C in therapy-naïve patients

✍ R. Gish; S. Arora; D. Nelson; H. Fernandez; K. Lamon 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Efficacy of peginterferon ALFA-2A (40KD)

Efficacy of peginterferon ALFA-2A (40KD) (PEGASYS) plud ribavirin for 24 weeks in genotype 1 patients with chronic hepatitis C followed by mono or combination therapy for 22 weeks: Preliminary analysis of an open, multicenter, randomized trial

✍ J.P. Bronowicki; D. Ouzan; T. Asselah; H. Desmorat; J.P. Zarski; J. Foucher; M. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 278 KB

Safety and efficacy of interferon alfa-2

Safety and efficacy of interferon alfa-2B and ribavirin combination therapy for the treatment of hepatitis C in patients coinfected with HIV: Edmund J Bini, Migdalia Reid, Rosemary A Mannix, VA New York Harbor Healthcare System, New York, NY; Bechien Wu, NYU School of Medicine, New York, NY

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Trends in sun exposure knowledge, attitu

Trends in sun exposure knowledge, attitudes, and behaviors: 1986 to 1996",June K. Robinson; Darrell S. Rigel; Rex A. Amonette 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80119-3,CME examination," 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80118-1,Antimicrobial agents for the dermatologist. I. β-Lactam antibiotics and related compounds,Marcia E. Epstein; Maria Amodio-Groton; Neil S. Sadick 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80140-5,Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis,P. Kullavanijaya; S. Reangchainam; R. Ungpakorn 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80143-0,Effect of topical pramoxine on experimentally induced pruritus in humans,Gil Yosipovitch; Howard I. Maibach 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80149-1,Treatment of psoriasis with the pulsed dye laser,S.W. Lanigan; G.A. Katugampola 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80147-8,Response rates in photopheresis therapy for cutaneous T-cell lymphoma,Herschel S. Zackheim; Mohammed Kashani-Sabet 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80136-3,Keratosis lichenoides chronica: Response to topical calcipotriol,Marcelo H. Grunwald; Dafna Hallel-Halevy; Boaz Amichai 01909622,37,1997,1,10.1016/s0190-9622(97)70209-3,Relation between expression of adhesion molecules and clinical behavior in cutaneous follicle center cell lymphomas,Rob C. Beljaards; Peter Van Beek; Rein Willemze 01909622,37,1997,1,10.1016/s0190-9622(97)70208-1,A novel nonepidermolytic palmoplantar keratoderma: A clinical and histopathologic study of six cases,Cynthia M. Magro; Lynn A. Baden; Arthur N. Crowson; Paul E. Bowden; Howard P. Baden 01909622,37,1997,1,10.1016/s0190-9622(97)70216-0,"Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect

✍ Gerald D. Weinstein; Gerald G. Krueger; Nicholas J. Lowe; Madeleine Duvic; David 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 765 KB